Advertisement

Cachexia in Chronic Kidney Disease: Malnutrition-Inflammation Complex and Reverse Epidemiology

  • Kamyar Kalantar-Zadeh
  • Joel D. Kopple

Abstract

Chronic kidney disease (CKD) is an irreversible and progressive disease state leading to renal dysfunction and related morbidity [1]. According to the National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) guidelines, CKD is defined as a chronic disease state in that irreversible, structural, or functional abnormalities of the kidney, with or without a decreased glomerular filtration rate (GFR), are present for at least three consecutive months [1]. The degree of renal insufficiency, based on the magnitude of the estimated GFR for 1.73 m2 body surface, is used to classify the CKD into five stages: (1) GFR > 90 ml/min, (2) GFR 60-89 ml/min, (3) GFR 30-59 ml/min, (4) GFR 15-29 ml/min, and (5) GFR < 15 ml/min [1]. If they survive long enough, CKD patients eventually reach stage 5 CKD, also known as end-stage renal disease (ESRD), in which life prolongation is exclusively dependent upon renal replacement therapy, i.e. maintenance haemodialysis or peritoneal dialysis treatment and/or kidney transplantation.

Keywords

Chronic Kidney Disease Peritoneal Dialysis Dialysis Patient Hemodialysis Patient Chronic Kidney Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266CrossRefGoogle Scholar
  2. 2.
    Keith DS, Nichols GA, Gullion CM et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663PubMedCrossRefGoogle Scholar
  3. 3.
    Jones CA, McQuillan GM, Kusek JW et al (1998) Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 32:992–999PubMedGoogle Scholar
  4. 4.
    Anonymous (2003) System USRD: USRD dy2003 Annual Data Report; Atlas of End Stage Renal Diseases in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, BethesdaGoogle Scholar
  5. 5.
    Hirth RA, Held PJ, Orzol SM, Dor A (1999) Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res 33:1567–1592PubMedGoogle Scholar
  6. 6.
    Garella S (1997) The costs of dialysis in the USA. Nephrol Dial Transplant 12(Suppl l):10–21PubMedGoogle Scholar
  7. 7.
    Anonymous (2002) United States Renal Data System: US Department of Public Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MarylandGoogle Scholar
  8. 8.
    Devereaux PJ, Schunemann HJ, Ravindran N et al (2002) Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA 288:2449–2457PubMedCrossRefGoogle Scholar
  9. 9.
    Eggers PW, Frankenfield DL, Greer JW et al (2002) Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. Am J Kidney Dis 39:796–804PubMedGoogle Scholar
  10. 10.
    Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12:2797–2806PubMedGoogle Scholar
  11. 11.
    Carlson DM, Duncan DA, Naessens JM, Johnson WJ (1984) Hospitalization in dialysis patients. Mayo Clin Proc 59:769–775PubMedGoogle Scholar
  12. 12.
    Fried L, Abidi S, Bernardini J et al (1999) Hospitalization in peritoneal dialysis patients. Am J Kidney Dis 33:927–933PubMedGoogle Scholar
  13. 13.
    Habach G, Bloembergen WE, Mauger EA et al (1995) Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis. J Am Soc Nephrol 5:1940–1948Google Scholar
  14. 14.
    Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16–S23PubMedCrossRefGoogle Scholar
  15. 15.
    Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119PubMedGoogle Scholar
  16. 16.
    Shlipak MG, Heidenreich PA, Noguchi H et al (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555–562PubMedGoogle Scholar
  17. 17.
    Shlipak MG, Simon JA, Grady D et al (2001) Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38:705–711PubMedCrossRefGoogle Scholar
  18. 18.
    Mann JF, Gerstein HC, Pogue J et al (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629–636PubMedGoogle Scholar
  19. 19.
    Fung F, Sherrard DJ, Gillen DL et al (2002) Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 40:307–314PubMedCrossRefGoogle Scholar
  20. 20.
    Kalantar-Zadeh K, Supasyndh O, Lehn RS et al (2003) Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 13:15–25PubMedCrossRefGoogle Scholar
  21. 21.
    Bergstrom J, Lindholm B (1999) Malnutrition, cardiac disease, and mortality. Perit Dial Int 19:S309–S314PubMedGoogle Scholar
  22. 22.
    Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343–1350PubMedGoogle Scholar
  23. 23.
    Qureshi AR, Alvestrand A, Divino-Filho JC et al (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13(Suppl 1):S28–S36PubMedGoogle Scholar
  24. 24.
    Zimmermann J, Herrlinger S, Pruyet P et al (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658PubMedCrossRefGoogle Scholar
  25. 25.
    Kalantar-Zadeh K, Kilpatrick RD, Kuwae K et al (2004) Population attributable mortality risk for albumin <3.8 g/dL: how many lives can be saved if hypoalbuminemia can be corrected in hemodialysis patients? 37th annual conference of the American Society of Nephrology; J Am Soc NephGoogle Scholar
  26. 26.
    Stenvinkel P, Heimburger O, Paultre F et al (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899–1911PubMedCrossRefGoogle Scholar
  27. 27.
    Bergstrom J (2000) Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease. Pol Arch Med Wewn 104:641–643PubMedGoogle Scholar
  28. 28.
    Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH (2001) A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251–1263PubMedGoogle Scholar
  29. 29.
    Pecoits-Filho R, Lindholm B, Stenvinkel P (2002) The malnutrition, inflammation, and atherosclerosis (MIA) syndrome — the heart of the matter. Nephrol Dial Transplant 17(Suppl 11):28–31PubMedGoogle Scholar
  30. 30.
    Newman Dorland W, Anderson D (2000) Dorland’s illustrated medical dictionary, WB Saunders, PhiladeplhiaGoogle Scholar
  31. 31.
    Kalantar-Zadeh K, Ikizler TA, Block G et al (2003) Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864–881PubMedCrossRefGoogle Scholar
  32. 32.
    Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454PubMedCrossRefGoogle Scholar
  33. 33.
    Kushner I (2003) Acute phase proteins, in UpToDate, edited by Rose B, Wellesley, MA, UpToDate, IncGoogle Scholar
  34. 34.
    Streetz KL, Wustefeld T, Klein C et al (2001) Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 47:661–673Google Scholar
  35. 35.
    Suffredini AF, Fantuzzi G, Badolato R et al (1999) New insights into the biology of the acute phase response. J Clin Immunol 19:203–214PubMedCrossRefGoogle Scholar
  36. 36.
    Owen WF, Lowrie EG (1998) C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627–663PubMedCrossRefGoogle Scholar
  37. 37.
    Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000) C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469–476PubMedGoogle Scholar
  38. 38.
    Zoccali C, Benedetto FA, Mallamaci F et al(2000) Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 18:1207–1213PubMedCrossRefGoogle Scholar
  39. 39.
    Iseki K, Tozawa M, Yoshi S, Fukiyama K (1999) Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14:1956–1960PubMedCrossRefGoogle Scholar
  40. 40.
    Noh H, Lee SW, Kang SW et al (1998) Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387–394PubMedGoogle Scholar
  41. 41.
    Kalantar-Zadeh K, Block G, McAllister CJ et al (2004) Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. Am J Clin Nutr 80:299–307PubMedGoogle Scholar
  42. 42.
    Shlipak MG, Chertow GC, Massie BM (2003) Beware the rising creatinine level. J Card Fail 9:26–28PubMedCrossRefGoogle Scholar
  43. 43.
    Lowbeer C, Stenvinkel P, Pecoits-Filho R et al (2003) Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 253:153–160PubMedCrossRefGoogle Scholar
  44. 44.
    Kalantar-Zadeh K, Kopple J (2006) Inflammation in renal failure, in UpToDate (vol 10.2), Boston, UpToDate, IncGoogle Scholar
  45. 45.
    Kalantar-Zadeh K, Stenvinkel P, Barba L et al (2003) Nutrition and Inflammation in Renal Insufficiency. Advances in Renal Replacement TherapyGoogle Scholar
  46. 46.
    Kaysen GA (2001) The micro inflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12:1549–1557PubMedGoogle Scholar
  47. 47.
    Kalantar-Zadeh K, Kopple J (2003) Inflammation in renal failure, in UpToDate (since Oct 2002), edited by Rose B, Wellesley, MA, UpToDate, IncGoogle Scholar
  48. 48.
    Kimmel PL, Phillips TM, Simmens SJ et al (1998) Immunologic function and survival in hemodialysis patients. Kidney Int 54:236–244PubMedCrossRefGoogle Scholar
  49. 49.
    Bologa RM, Levine DM, Parker TS et al (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107–114PubMedGoogle Scholar
  50. 50.
    Pecoits-Filho R, Barany P, Lindholm B et al (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684–1688PubMedCrossRefGoogle Scholar
  51. 51.
    Stenvinkel P, Barany P, Heimburger O et al (2002) Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl:103–108Google Scholar
  52. 52.
    Tatli MM, Vural H, Koc A et al(2000) Altered antioxidant status and increased lipid peroxidation in marasmic children. Pediatr Int 42:289–292PubMedCrossRefGoogle Scholar
  53. 53.
    Torun B, Chew F (1999) Protein-energy malnutrition. In: Shils M, Olson J, Shike M, Ross A (eds) Modern nutrition in health and disease, 9th ed. William & Wilkins, Baltimore, pp 963–988Google Scholar
  54. 54.
    Kopple JD, Levey AS, Greene T et al (1997) Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 52:778–791PubMedCrossRefGoogle Scholar
  55. 55.
    Kopple JD, Greene T, Chumlea WC et al (2000) Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 57:1688–1703PubMedCrossRefGoogle Scholar
  56. 56.
    Kopple JD (1997) Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43:246–250PubMedCrossRefGoogle Scholar
  57. 57.
    Kopple JD, Zhu X, Lew NL, Lowrie EG (1999) Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56:1136–1148PubMedCrossRefGoogle Scholar
  58. 58.
    Mehrotra R, Kopple JD (2001) Nutritional management of maintenance dialysis patients: why aren’t we doing better? Annu Rev Nutr 21:343–379PubMedCrossRefGoogle Scholar
  59. 59.
    Kalantar-Zadeh K, Kopple JD (2003) Nutritional management of hemodialysis patients. In:Kopple JD, Massry S (eds) Nutritional management of renal disease, 2nd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  60. 60.
    Kalantar-Zadeh K, Kopple JD, Deepak S et al (2002) Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 12:17–31PubMedCrossRefGoogle Scholar
  61. 61.
    Kalantar-Zadeh K, Kopple JD (2003) Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther 10:170–182PubMedGoogle Scholar
  62. 62.
    Kopple JD (1997) McCollum Award Lecture 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65:1544–1557PubMedGoogle Scholar
  63. 63.
    Kopple JD (1999) Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr 129:247S–251SPubMedGoogle Scholar
  64. 64.
    Mehrotra R, Kopple JD (2003) Causes of proteinenergy malnutrition in chronic renal failure. In: Kopple JD, Massry S (eds) Nutritional management of renal disease, 2nd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  65. 65.
    Qureshi AR, Alvestrand A, Danielsson A et al (1998) Factors predicting malnutrition in hemodialysis patients: a crosssectional study. Kidney Int 53:773–782PubMedCrossRefGoogle Scholar
  66. 66.
    Bergstrom J (1995) Why are dialysis patients malnourished? Am J Kidney Dis 26:229–241PubMedGoogle Scholar
  67. 67.
    Ikizler TA, Greene JH, Wingard RL et al (1995) Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386–1391PubMedGoogle Scholar
  68. 68.
    Kalantar-Zadeh K, Kleiner M, Dunne E et al (1998) Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 31:263–272PubMedGoogle Scholar
  69. 69.
    Enia G, Sicuso C, Alati G, Zoccali C (1993) Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8:1094–1098PubMedGoogle Scholar
  70. 70.
    Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G (2004) Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 19:1507–1519PubMedCrossRefGoogle Scholar
  71. 71.
    Kalantar-Zadeh K, Kopple JD (2003) Malnutrition as a cause of morbidity and mortality in dialysis patients. In: Kopple JD, Massry S (eds) Nutritional management of renal disease, 2nd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  72. 72.
    Kalantar-Zadeh K, Block G, McAllister CJ et al (2003) Association between self-reported appetite and markers of inflammation, nutrition, anemia and quality of life in hemodialysis patients. Am J Clin NutritionGoogle Scholar
  73. 73.
    Culp K, Flanigan M, Dudley J et al (1998) Using the Quetelet body mass index as a mortality indicator for patients starting renal replacement therapy. ANNA J 25:321–330; discussion 331–322PubMedGoogle Scholar
  74. 74.
    Leavey SF, McCullough K, Hecking E et al (2001) Body mass index and mortality in ‘healthier’ as compared with’ sicker’ haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16:2386–2394PubMedCrossRefGoogle Scholar
  75. 75.
    Port FK, Ashby VB, Dhingra RK et al (2002) Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061–1066PubMedGoogle Scholar
  76. 76.
    Kalantar-Zadeh K, Block G, Kelly MP et al (2001) Near infra-red interactance for longitudinal assessment of nutrition in dialysis patients. J Ren Nutr 11:23–31PubMedGoogle Scholar
  77. 77.
    Blumenkrantz MJ, Kopple JD, Gutman RA et al (1980) Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33:1567–1585PubMedGoogle Scholar
  78. 78.
    Pollock CA, Ibels LS, Allen BJ et al (1995) Total body nitrogen as a prognostic marker in maintenance dialysis. J Am Soc Nephrol 6:82–88PubMedGoogle Scholar
  79. 79.
    Arora P, Strauss BJ, Borovnicar D et al(1998) Total body nitrogen predicts long-term mortality in haemodialysis patients—a single-centre experience. Nephrol Dial Transplant 13:1731–1736PubMedCrossRefGoogle Scholar
  80. 80.
    Boddy K, King PC, Lindsay RM et al (1972) Total body potassium in non-dialysed and dialysed patients with chronic renal failure. Br Med J 1:771–775PubMedGoogle Scholar
  81. 81.
    Wolfson M, Strong CJ, Minturn D et al (1984) Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 39:547–555PubMedGoogle Scholar
  82. 82.
    Kaysen GA, Levin N (2002) Why measure serum albumin levels? J Ren Nutr 12:148–150PubMedCrossRefGoogle Scholar
  83. 83.
    Sreedhara R, Avram MM, Blanco M et al (1996) Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 28:937–942PubMedGoogle Scholar
  84. 84.
    Kopple JD, Mehrotra R, Suppasyndh O et al (2002) Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure. Clin Chem Lab Med 40:1308–1312PubMedCrossRefGoogle Scholar
  85. 85.
    Neyra NR, Hakim RM, Shyr Y, Ikizler TA (2000) Serum transferrin and serum prealbumin are early predictors of serum albumin in chronic hemodialysis patients. J Ren Nutr 10:184–190PubMedGoogle Scholar
  86. 86.
    Avram MM, Fein PA, Antignani A et al (1989) Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 87:55N–60NPubMedGoogle Scholar
  87. 87.
    Iseki K, Yamazato M, Tozawa M, Takishita S (2002) Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61:1887–1893PubMedCrossRefGoogle Scholar
  88. 88.
    Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–482PubMedGoogle Scholar
  89. 89.
    Cooper BA, Bartlett LH, Aslani A et al (2002) Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 40:126–132PubMedCrossRefGoogle Scholar
  90. 90.
    Visser R, Dekker FW, Boeschoten EW et al (1999) Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial 15:222–225PubMedGoogle Scholar
  91. 91.
    Kaysen GA, Dubin JA, Muller HG et al (2002) Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61:2240–2249PubMedCrossRefGoogle Scholar
  92. 92.
    Grodstein GP, Blumenkrantz MJ, Kopple JD (1980) Nutritional and metabolic response to catabolic stress in uremia. Am J Clin Nutr 33:1411–1416PubMedGoogle Scholar
  93. 93.
    Chertow GM (1999) Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time? J Ren Nutr 9:138–141PubMedGoogle Scholar
  94. 94.
    Dumler F (1997) Use of bioelectric impedance analysis and dual-energy X-ray absorptiometry for monitoring the nutritional status of dialysis patients. ASAIO J 43:256–260PubMedGoogle Scholar
  95. 95.
    Pollock CA, Allen BJ, Warden RA et al (1990) Total body nitrogen by neutron activation analysis in maintenance dialysis patients. Am J Kidney Dis 16:38–45PubMedGoogle Scholar
  96. 96.
    Ikizler TA, Hakim RM (1996) Nutrition in end-stage renal disease. Kidney Int 50:343–357PubMedCrossRefGoogle Scholar
  97. 97.
    Kalantar-Zadeh K, Dunne E, Nixon K et al (1999) Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant 14:169–175PubMedCrossRefGoogle Scholar
  98. 98.
    Yeun JY, Kaysen GA (1998) Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 32:S118–S125PubMedGoogle Scholar
  99. 99.
    Stenvinkel P, Barany P, Chung SH et al (2002) A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol Dial Transplant 17:1266–1274PubMedCrossRefGoogle Scholar
  100. 100.
    Kaizu Y, Kimura M, Yoneyama T et al (1998) Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31:93–100PubMedGoogle Scholar
  101. 101.
    Flores EA, Bistrian BR, Pomposelli JJ et al (1989) Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin l. J Clin Invest 83:1614–1622PubMedGoogle Scholar
  102. 102.
    Espat NJ, Copeland EM, Moldawr LL (1994) Tumor necrosis factor and cachexia: a current perspective. Surg One 3:255–262CrossRefGoogle Scholar
  103. 103.
    McCarthy DO (2000) Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health 23:222–228PubMedCrossRefGoogle Scholar
  104. 104.
    Kaysen GA, Chertow GM, Adhikarla R et al (2001) Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333–340PubMedCrossRefGoogle Scholar
  105. 105.
    Kaysen GA, Stevenson FT, Depner TA (1997) Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29:658–668PubMedGoogle Scholar
  106. 106.
    Ginn HE, Frost A, Lacy WW (1968) Nitrogen balance in hemodialysis patients. Am J Clin Nutr 21:385–393PubMedGoogle Scholar
  107. 107.
    Kaysen GA, Dubin JA, Muller HG et al (2000) The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 58:346–352PubMedCrossRefGoogle Scholar
  108. 108.
    Leon JB, Majerle AD, Soinski JA et al (2001) Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr 11:9–15Google Scholar
  109. 109.
    Kuhlmann MK, Schmidt F, Kohler H (1999) High protein/energy vs. standard protein/energy nutritional regimen in the treatment of malnourished hemodialysis patients. Miner Electrolyte Metab 25:306–310PubMedCrossRefGoogle Scholar
  110. 110.
    Pupim LB, Flakoll PJ, Brouillette JR et al (2002) Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 110:483–492PubMedCrossRefGoogle Scholar
  111. 111.
    Caglar K, Fedje L, Dimmitt R et al (2002) Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 62:1054–1059PubMedCrossRefGoogle Scholar
  112. 112.
    Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U (1998) A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13:2594–2600PubMedCrossRefGoogle Scholar
  113. 113.
    Hulsewe KW, van Acker BA, von Meyenfeldt MF, Soeters PB (1999) Nutritional depletion and dietary manipulation: effects on the immune response. World J Surg 23:536–544PubMedCrossRefGoogle Scholar
  114. 114.
    De Simone C, Famularo G, Tzantzoglou S et al (1994) Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral Lcarnitine. AIDS 8:655–660PubMedCrossRefGoogle Scholar
  115. 115.
    Ridker PM, Rifai N, Rose L et al (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565PubMedCrossRefGoogle Scholar
  116. 116.
    Kaysen GA (2000) Malnutrition and the acute-phase reaction in dialysis patients-how to measure and how to distinguish. Nephrol Dial Transplant 15:1521–1524PubMedCrossRefGoogle Scholar
  117. 117.
    Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD (2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63:793–808PubMedCrossRefGoogle Scholar
  118. 118.
    Barany P, Divino Filho JC, Bergstrom J (1997) High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29:565–568PubMedGoogle Scholar
  119. 119.
    Stenvinkel P, Alvestrand A (2002) Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 15:329–337PubMedCrossRefGoogle Scholar
  120. 120.
    Gunnell J, Yeun JY, Depner TA, Kaysen GA (1999) Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33:63–72PubMedGoogle Scholar
  121. 121.
    Goicoechea M, Martin J, de Sequera P et al (1998) Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337–1343PubMedCrossRefGoogle Scholar
  122. 122.
    Sitter T, Bergner A, Schiffl H (2000) Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 15:1207–1211PubMedCrossRefGoogle Scholar
  123. 123.
    Kalantar-Zadeh K, Fouque D, Kopple JD (2004) Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients. J Ren Nutr 14:64–71PubMedCrossRefGoogle Scholar
  124. 124.
    Kalantar-Zadeh K, McAllister CJ, Lehn RS et al (2003) Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42:761–773PubMedCrossRefGoogle Scholar
  125. 125.
    Hurot JM, Cucherat M, Haugh M, Fouque D (2002) Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol 13:708–714PubMedGoogle Scholar
  126. 126.
    Navarro JF, Mora C (2001) In-depth review effect of androgens on anemia and malnutrition in renal failure: implications for patients on peritoneal dialysis. Perit Dial Int 21:14–24PubMedGoogle Scholar
  127. 127.
    Brox AG, Zhang F, Guyda H, Gagnon RF (1996) Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse. Kidney Int 50:937–943PubMedCrossRefGoogle Scholar
  128. 128.
    Voulgari PV, Kolios G, Papadopoulos GK et al (1999) Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 92:153–160PubMedCrossRefGoogle Scholar
  129. 129.
    Stenvinkel P (2001) The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 16(Suppl 7):36–40PubMedGoogle Scholar
  130. 130.
    Stenvinkel P, Barany P (2002) Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 17(Suppl 5):32–37PubMedCrossRefGoogle Scholar
  131. 131.
    Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH (2001) Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 37:564–572PubMedCrossRefGoogle Scholar
  132. 132.
    Kalantar-Zadeh K, Luft FC, Humphreys MH (1999) Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients. Kidney Int 56:758–759PubMedGoogle Scholar
  133. 133.
    Miller CB, Jones RJ, Piantadosi S et al (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689–1692PubMedCrossRefGoogle Scholar
  134. 134.
    Jelkmann W, Pagel H, Wolff M, Fandrey J (1992) Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 50:301–308PubMedCrossRefGoogle Scholar
  135. 135.
    Means RT Jr, Krantz SB (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639–1647PubMedGoogle Scholar
  136. 136.
    Schooley JC, Kullgren B, Allison AC (1987) Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br J Haematol 67:11–17PubMedGoogle Scholar
  137. 137.
    Becker AE, de Boer OJ, van Der Wal AC (2001) The role of inflammation and infection in coronary artery disease. Annu Rev Med 52:289–297PubMedCrossRefGoogle Scholar
  138. 138.
    Girndt M, Kaul H, Sester U et al (2002) Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949–955PubMedCrossRefGoogle Scholar
  139. 139.
    Kaplan N (2001) Risk factor for atherosclerotic disease. In: Braunwald EZD, Libby P(eds) Heart disease: a textbook of cardiovascular medicine Saunders WB, Philadelphia, PA, pp 1010–1039Google Scholar
  140. 140.
    Haubitz M, Brunkhorst R (2001) C-reactive protein and chronic Chlamydia pneumoniae infectionlong-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16:809–815PubMedCrossRefGoogle Scholar
  141. 141.
    Stenvinkel P, Heimburger O, Jogestrand T (2002) Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39:274–282PubMedGoogle Scholar
  142. 142.
    Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437–444PubMedCrossRefGoogle Scholar
  143. 143.
    Pecoits-Filho R, Stenvinkel P, Marchlewska A et al (2003) A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl:172–176Google Scholar
  144. 144.
    Mezzano D, Pais EO, Aranda E et al (2001) Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60:1844–1850PubMedCrossRefGoogle Scholar
  145. 145.
    Chung SH, Stenvinkel P, Heimburger O et al (2000) Prevention and treatment of the malnutrition, inflammation and atherosclerosis (MIA) syndrome in uremic patients. Pol Arch Med Wewn 104:645–654PubMedGoogle Scholar
  146. 146.
    Foley RN, Parfrey PS, Harnett JD et al (1996) Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728–736PubMedGoogle Scholar
  147. 147.
    Fleischmann E, Teal N, Dudley J et al (1999) Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560–1567PubMedCrossRefGoogle Scholar
  148. 148.
    Iseki K, Ikemiya Y, Fukiyama K (1997) Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int Suppl 63:S169–S170PubMedGoogle Scholar
  149. 149.
    Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ et al (2004) Time-dependant association between body mass index and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 15:126ACrossRefGoogle Scholar
  150. 150.
    Kalantar-Zadeh K, Block G, Humphreys MH et al (2004) A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15:442–453PubMedCrossRefGoogle Scholar
  151. 151.
    Lowrie EG (1983) History and organization of the National Cooperative Dialysis Study. Kidney Int Suppl 13:S1–S7PubMedGoogle Scholar
  152. 152.
    Ritz E (1996) Why are lipids not predictive of cardiovascular death in the dialysis patient? Miner Electrolyte Metab 22:9–12PubMedGoogle Scholar
  153. 153.
    Lowrie EG (1997) Conceptual model for a core pathobiology of uremia with special reference to anemia, malnourishment, and mortality among dialysis patients. Semin Dial 9:115–129CrossRefGoogle Scholar
  154. 154.
    Suliman ME, Lindholm B, Barany P, Bergstrom J (2001) Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease. Clin Chem Lab Med 39:734–738PubMedCrossRefGoogle Scholar
  155. 155.
    Suliman ME, Qureshi AR, Barany P et al (2000) Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 57:1727–1735PubMedCrossRefGoogle Scholar
  156. 156.
    Suliman ME, Stenvinkel P, Barany P et al (2003) Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 41:S89–S95PubMedGoogle Scholar
  157. 157.
    Bostom A, Brosnan JT, Hall B et al (1995) Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59–62PubMedCrossRefGoogle Scholar
  158. 158.
    Iseki K, Miyasato F, Tokuyama K et al (1997) Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51:1212–1217PubMedCrossRefGoogle Scholar
  159. 159.
    Marckmann P (1989) Nutritional status and mortality of patients in regular dialysis therapy. J Intern Med 226:429–432PubMedGoogle Scholar
  160. 160.
    Lawson JA, Lazarus R, Kelly JJ (2001) Prevalence and prognostic significance of malnutrition in chronic renal insufficiency. J Ren Nutr 11:16–22PubMedGoogle Scholar
  161. 161.
    Anonymous (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 7:198–207Google Scholar
  162. 162.
    Anonymous (2000) National Kidney Foundation, Kidney Disease-Dialysis Outcome Quality Initiative: K/DOQI Clinical Practice Guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35:S1–S14OGoogle Scholar
  163. 163.
    Anonymous (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 7:198–207Google Scholar
  164. 164.
    Kalantar-Zadeh K, Kleiner M, Dunne E et al (1999) A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 14:1732–1738PubMedCrossRefGoogle Scholar
  165. 165.
    Kopple JD, Massry SG (1996) Nutritional management of renal disease. In: Kopple JD (ed) Nutritional management of nondialyzed patients with chronic renal failure, edited by JDK, William and Wilkins, Baltimore, pp 479–531Google Scholar
  166. 166.
    Mortelmans AK, Duym P, Vandenbroucke J et al (1999) Intradialytic parenteral nutrition in malnourished hemodialysis patients: a prospective long-term study. JPEN J Parenter Enterai Nutr 23:90–95Google Scholar
  167. 167.
    Koretz RL (1999) Does nutritional intervention in protein-energy malnutrition improve morbidity or mortality? J Ren Nutr 9:119–121Google Scholar
  168. 168.
    Foulks CJ (1994) The effect of intradialytic parenteral nutrition on hospitalization rate and mortality in malnourished hemodialysis patients. J Renal Nutr 4:5–10Google Scholar
  169. 169.
    Chertow GM, Owen WF, Lazarus JM (1994) Outcomes of older patients receiving chronic dialysis. JAMA 272:274PubMedCrossRefGoogle Scholar
  170. 170.
    Capelli JP, Kushner H, Camiscioli TC et al (1994) Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 23:808–816PubMedGoogle Scholar
  171. 171.
    Siskind MS, Lien YH (1993) Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs 16:599–603PubMedGoogle Scholar
  172. 172.
    Pupim LB, Kent P, Hakim R (1999) The potential of intradialytic parenteral nutrition: a review. Miner Electrolyte Metab 25:317–323PubMedCrossRefGoogle Scholar
  173. 173.
    Foulks CJ (1999) An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 33:186–192PubMedGoogle Scholar
  174. 174.
    Boccanfuso JA, Hutton M, McAllister B (2000) The effects of megestrol acetate on nutritional parameters in a dialysis population. J Ren Nutr 10:36–43PubMedGoogle Scholar
  175. 175.
    Semeniuk J, Shalansky KF, Taylor N et al (2000) Evaluation of the effect of intravenous 1-carnitine on quality of life in chronic hemodialysis patients. Clin Nephrol 54:470–477PubMedGoogle Scholar
  176. 176.
    Chazot C, Laurent G, Charra B et al (2001) Malnutrition in long-term haemodialysis survivors. Nephrol Dial Transplant 16:61–69PubMedCrossRefGoogle Scholar
  177. 177.
    Johannsson G, Bengtsson BA, Ahlmen (1999) Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. Am J Kidney Dis 33:709–717PubMedGoogle Scholar
  178. 178.
    Fouque D, Peng SC, Shamir E, Kopple JD (2000) Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 57:646–654PubMedGoogle Scholar
  179. 179.
    Johnson CA (2000) Use of androgens in patients with renal failure. Semin Dial 13:36–39PubMedCrossRefGoogle Scholar
  180. 180.
    Chang JW, Yang WS, Min WK et al (2002) Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis 39:1213–1217PubMedCrossRefGoogle Scholar
  181. 181.
    Seliger SL, Weiss NS, Gillen DL et al (2002) HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 61:297–304PubMedCrossRefGoogle Scholar
  182. 182.
    Stenvinkel P, Andersson P, Wang T et al (1999) Do ACE-inhibitors suppress tumour necrosis factoralpha production in advanced chronic renal failure? J Intern Med 246:503–507PubMedCrossRefGoogle Scholar
  183. 183.
    Boaz M, Smetana S, Weinstein T et al (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213–1218PubMedCrossRefGoogle Scholar
  184. 184.
    Abbey M (1995) The importance of vitamin E in reducing cardiovascular risk. Nutr Rev 53:S28–S32PubMedGoogle Scholar
  185. 185.
    Hoogwerf BJ, Young JB (2000) The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med 67:287–293PubMedGoogle Scholar
  186. 186.
    Lonn E, Yusuf S, Hoogwerf B et al (2002) Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25:1919–1927PubMedCrossRefGoogle Scholar
  187. 187.
    Clermont G, Lecour S, Cabanne JF et al (2001) Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med 31:233–241PubMedCrossRefGoogle Scholar
  188. 188.
    Bloembergen WE, Hakim RM, Stannard DC et al (1999) Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 33:1–10PubMedGoogle Scholar
  189. 189.
    Schindler R, Boenisch O, Fischer C, Frei U (2000) Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 53:452–459PubMedGoogle Scholar
  190. 190.
    Memoli B, Minutolo R, Bisesti V et al (2002) Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. Am J Kidney Dis 39:266–273PubMedGoogle Scholar
  191. 191.
    Chertow GM, Johansen KL, Lew N et al (2000) Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 57:1176–1181PubMedCrossRefGoogle Scholar
  192. 192.
    Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC (2004) Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43:1439–1444PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Kamyar Kalantar-Zadeh
    • 1
  • Joel D. Kopple
    • 2
  1. 1.Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Division of Nephrology and Hypertension, and David Geffen School of MedicineUniversity of California Los AngelesLos AngelesUSA
  2. 2.Division of Public HealthNutrition and Epidemiology, University of California Berkeley School of Public Health, Berkeley and UCLA School of Public HealthLos AngelesUSA

Personalised recommendations